Dostarlimab with platinum-based chemotherapy for treating primary advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency
Technology appraisal guidance
Reference number: TA1064
Published:
Evidence
Documents containing the evidence that was used to develop the recommendations.